--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 666.670K--
--2024/Q20.000 / 500.000K--
--2024/Q10.000 / 333.330K--
Meta Platforms
META
Alphabet-C
GOOG
Alphabet-A
GOOGL
Vale SA
VALE
Coinbase
COIN
US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 6.340
- +0.070+1.12%
Close Jan 24 16:00 ET
- 6.340
- 0.0000.00%
Post 16:00 ET
46.26MMarket Cap-0.48P/E (TTM)
6.400High6.230Low15.25KVolume6.270Open6.270Pre Close96.70KTurnover0.34%Turnover RatioLossP/E (Static)7.30MShares11.35052wk High0.35P/B28.87MFloat Cap5.20252wk Low--Dividend TTM4.55MShs Float363.268Historical High--Div YieldTTM2.71%Amplitude5.200Historical Low6.340Avg Price1Lot Size
Kezar Life Sciences Key Stats
Kezar Life Sciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Kezar Life Sciences Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data